Hip Surgery for Bone Cancer
(PERFORM Trial)
Trial Summary
What is the purpose of this trial?
The goal of this clinical trial is to find out if removing and replacing part of the hip bone works better than using metal hardware to stabilize the bone in patients whose cancer has spread to the hip. The main questions are: 1. Does removing and replacing part of the bone work better than just stabilizing it with metal hardware? 2. Does removing and replacing the bone help reduce problems like cancer coming back or the metal hardware breaking? Researchers will compare two treatments: using metal rods and plates to stabilize the bone (internal fixation) versus removing part of the bone and possibly replacing the hip joint (resection and reconstruction) to see if the second option causes fewer problems. Participants will: * Be randomly assigned to one of two groups (internal fixation or resection and reconstruction). * Have one of the two surgeries based on which group they're in. * Go to follow-up appointments with the study doctor at 2 weeks, 6 weeks, 4 months, 6 months, 9 months, and 12 months after surgery.
Research Team
Michelle Ghert, MD
Principal Investigator
McMaster University
Eligibility Criteria
The PERFORM trial is for patients with cancer that has spread to the hip bone. They should be fit enough for surgery and willing to follow up regularly after the procedure. Specific criteria about who can or cannot participate are not provided here.Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- Internal Fixation (Procedure)
- Resection and reconstruction (Procedure)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Michelle Ghert, MD
Lead Sponsor
Canadian Cancer Society (CCS)
Collaborator